|Bid||64.35 x 100|
|Ask||65.00 x 100|
|Day's Range||64.23 - 64.79|
|52 Week Range||63.88 - 88.85|
|PE Ratio (TTM)||6.80|
|Dividend & Yield||2.08 (3.23%)|
|1y Target Est||N/A|
Amgen is a great dividend stock. Here's why Gilead Sciences is even better.
Inovio Pharmaceuticals' experimental HIV vaccine is off to a promising start.
Falling hepatitis C sales are dragging sales and profit lower. Here's what could happen next.